See more : Wan Cheng Metal Packaging Company Limited (8291.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Li Kang Biomedical Co., Ltd. (6242.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Li Kang Biomedical Co., Ltd., a leading company in the None industry within the None sector.
You may be interested
- TI Fluid Systems plc (TIFS.L) Income Statement Analysis – Financial Results
- Shih-Kuen Plastics Co., Ltd. (4305.TWO) Income Statement Analysis – Financial Results
- CSP Steel Center Public Company Limited (CSP.BK) Income Statement Analysis – Financial Results
- PAX Global Technology Limited (0327.HK) Income Statement Analysis – Financial Results
- Xynergy Holdings, Inc. (XYNH) Income Statement Analysis – Financial Results
Li Kang Biomedical Co., Ltd. (6242.TWO)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 629.38M | 684.25M | 386.97M | 456.72M | 0.00 |
| Cost of Revenue | 203.23M | 295.68M | 122.29M | 156.09M | 0.00 |
| Gross Profit | 426.15M | 388.58M | 264.68M | 300.64M | 0.00 |
| Gross Profit Ratio | 67.71% | 56.79% | 68.40% | 65.82% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 3.00K |
| General & Administrative | 46.74M | 42.77M | 37.49M | 39.59M | 0.00 |
| Selling & Marketing | 246.03M | 208.45M | 169.95M | 180.12M | 0.00 |
| SG&A | 292.77M | 251.22M | 207.44M | 219.71M | 0.00 |
| Other Expenses | 0.00 | 2.18M | 5.49M | 5.36M | 0.00 |
| Operating Expenses | 292.77M | 251.22M | 207.44M | 219.70M | 0.00 |
| Cost & Expenses | 496.01M | 546.89M | 329.72M | 375.78M | 0.00 |
| Interest Income | 3.27M | 1.55M | 1.20M | 1.19M | 1.24M |
| Interest Expense | 618.00K | 290.00K | 455.00K | 546.00K | 779.00K |
| Depreciation & Amortization | 11.74M | 10.99M | 12.89M | 15.02M | 0.00 |
| EBITDA | 151.37M | 152.07M | 76.83M | 102.51M | 106.08M |
| EBITDA Ratio | 24.05% | 22.22% | 19.85% | 22.44% | 0.00% |
| Operating Income | 133.37M | 141.09M | 63.94M | 87.49M | 0.00 |
| Operating Income Ratio | 21.19% | 20.62% | 16.52% | 19.16% | 0.00% |
| Total Other Income/Expenses | 5.77M | 3.44M | 6.24M | 6.00M | 3.03M |
| Income Before Tax | 139.14M | 140.80M | 63.48M | 86.94M | 0.00 |
| Income Before Tax Ratio | 22.11% | 20.58% | 16.40% | 19.04% | 0.00% |
| Income Tax Expense | 28.15M | 28.70M | 12.05M | 17.68M | 0.00 |
| Net Income | 110.99M | 112.09M | 51.44M | 69.27M | 0.00 |
| Net Income Ratio | 17.64% | 16.38% | 13.29% | 15.17% | 0.00% |
| EPS | 4.14 | 4.18 | 1.86 | 2.50 | 0.00 |
| EPS Diluted | 4.12 | 4.16 | 1.85 | 2.48 | 0.00 |
| Weighted Avg Shares Out | 26.81M | 27.73M | 27.72M | 27.72M | 27.72M |
| Weighted Avg Shares Out (Dil) | 26.96M | 27.88M | 27.85M | 27.92M | 27.92M |
No news found for: 6242.TWO
Source: https://incomestatements.info
Category: Stock Reports